Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer: ASCO Guideline Update Q and A

被引：1
|
作者：
Raab, Rachel [1 ]
Ismaila, Nofisat [2 ]
Andre, Fabrice [3 ]
Stearns, Vered [4 ]
Kalinsky, Kevin [5 ]
机构：
[1] Messino Canc Ctr, Asheville, NC USA
[2] Amer Soc Clin Oncol, 2318 Mill Rd,Ste 800, Alexandria, VA 22314 USA
[3] Inst Gustave Roussy, Paris, France
[4] Johns Hopkins Univ, Baltimore, MD USA
[5] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA
来源：
JCO ONCOLOGY PRACTICE | 2022年 / 18卷 / 09期
关键词：
DISTANT RECURRENCE; PREDICTION; INDEX; DECISIONS; THERAPY;
D O I：
10.1200/OP.22.00230
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：646 / +
页数：4
相关论文
共 50 条
  • [41] Use of Immune Checkpoint Inhibitors in the Treatment of High-Risk, Early-Stage Triple-Negative Breast Cancer: ASCO Guideline Rapid Recommendation Update Q and A
    Vikas, Praveen
    Korde, Larissa A.
    Somerfield, Mark R.
    Hershman, Dawn L.
    [J]. JCO ONCOLOGY PRACTICE, 2022, 18 (09) : 649 - +
  • [42] Adjuvant bisphosphonates for early-stage breast cancer
    Brufsky, Adam
    [J]. LANCET ONCOLOGY, 2011, 12 (07): : 610 - 611
  • [43] Prognostic & predictive factors for planning adjuvant chemotherapy of early-stage breast cancer
    Esbah, Onur
    Oksuzoglu, Berna
    [J]. INDIAN JOURNAL OF MEDICAL RESEARCH, 2017, 146 : 563 - 571
  • [44] Neratinib in the Early-Stage/Extended Adjuvant Breast Cancer Patient: Q&A
    O'Shaughnessy, Joyce A.
    O'Regan, Ruth
    Isaacs, Claudine
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (08) : 16 - 17
  • [45] Is paclitaxel cost-effective for the adjuvant chemotherapy in early-stage breast cancer?
    Limwattananon, S
    Limwattananon, C
    Maoleekulpairoj, S
    Soparatanapaisal, N
    [J]. PHARMACOTHERAPY, 2005, 25 (10): : 1473 - 1473
  • [46] Simulation modeling of the effects of adjuvant chemotherapy in early-stage breast cancer.
    Jayasekera, Jinani
    Schechter, Clyde B.
    Sparano, Joseph A.
    Isaacs, Claudine
    Gray, Robert James
    Cadham, Christopher
    Mandelblatt, Jeanne S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [47] Patients' preferences for adjuvant chemotherapy in early-stage breast cancer: is treatment worthwhile?
    Jansen, SJT
    Kievit, J
    Nooij, MA
    de Haes, JCJM
    Overpelt, IME
    van Slooten, H
    Maartense, E
    Stiggelbout, AM
    [J]. BRITISH JOURNAL OF CANCER, 2001, 84 (12) : 1577 - 1585
  • [48] Can some patients avoid adjuvant chemotherapy for early-stage breast cancer?
    Bedard, Philippe L.
    Cardoso, Fatima
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2011, 8 (05) : 272 - 279
  • [49] Can some patients avoid adjuvant chemotherapy for early-stage breast cancer?
    Philippe L. Bedard
    Fatima Cardoso
    [J]. Nature Reviews Clinical Oncology, 2011, 8 : 272 - 279
  • [50] Patients’ preferences for adjuvant chemotherapy in early-stage breast cancer: is treatment worthwhile?
    S J T Jansen
    J Kievit
    M A Nooij
    J C J M de Haes
    I M E Overpelt
    H van Slooten
    E Maartense
    A M Stiggelbout
    [J]. British Journal of Cancer, 2001, 84 : 1577 - 1585
12345